Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
about
Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismA turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityNew horizons and perspectives in the treatment of osteoarthritisNSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesPolypharmacy in Older Adults With Hypertension: A Comprehensive ReviewCardiovascular comorbidity in rheumatic diseases: a focus on heart failureNew insights into the use of currently available non-steroidal anti-inflammatory drugsThe Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-AnalysisReview of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulationsTramadol Extended-Release for the Management of Pain due to OsteoarthritisMitigating the cardiovascular and renal effects of NSAIDsPiroxicam-β-cyclodextrin: a GI safer piroxicamGastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesThe big idea: the coxib crisis iron, aspirin and heart disease risk revisitedAnithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapyCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardCause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide studyAlleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsClinical Pharmacology and Cardiovascular Safety of NaproxenEstablishing an integrated gastroenterology service between a medical center and the community.Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective dataThe potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksCOX-2 inhibition: what we learned--a controversial update on safety data.The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data.Clinical trial data in support of changing guidelines in osteoarthritis treatment.Evidence and consensus recommendations for the pharmacological management of pain in India.Non-steroidal anti-inflammatory drugs and their benefits and harms: the challenge of interpreting meta-analyses and observational data sets when balanced data are not analyzed and reported.Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trialsLesion mimicking perianal abscess in an immunocompromised patient: Report of a case.Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillanceIncreased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communityPharmacologic management of chronic pain.Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouseRandomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety.Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.Viscosupplementation during rehabilitation.
P2860
Q21284705-08B33E84-BA83-48A5-9FA3-5815E06A1EF8Q24615651-42E2FD9C-0C8D-4BD4-AA9A-597DA5EA4732Q24657795-A1AD3838-4F23-47E9-932F-2A6DA8DC18A3Q26784322-1FD4DF71-8791-4B7E-A628-E8B6C7A601E0Q26799236-6C3CAC03-AFA4-4209-BE81-6848D27DF8ECQ26823443-BDC40B12-0D14-47AE-9A1A-91427C0259F2Q26852330-A3446A46-36AC-4046-895E-4AE9A4D81315Q26860726-181E1C05-7D17-444B-8232-6DCCD96AC59DQ27000905-0A8F7880-F280-498D-BBD6-C426632FCC5EQ27015822-1EB7FDE6-48DD-4F92-85AE-0F0A94DA719FQ27022837-93821A87-8A77-4DC5-97B5-DB3E2507DCA8Q27023475-980BB7A4-9ADA-4A6E-BDFA-2733DE77F1CFQ27026351-ADC0C286-BD62-4719-AB87-7CD671248444Q28217914-7E646A50-8BB6-4DAD-ACBE-756A2DA1050CQ28220433-5D0B8B85-0B58-44BD-B829-4985576285E3Q28274081-8A52DC61-68F9-4A24-B3D4-B0E25B32073DQ28485380-5C5247D2-A72F-450D-9730-F470406ABDE3Q30234292-430C555B-3DD0-44F9-A134-09E15A2B0899Q30360728-2B250923-E0D4-49C1-AA27-DE4E52904EE3Q30487677-42B8A486-7CFA-4803-BF69-5BF49091BFFBQ30570853-16272799-6A24-4767-944E-F12E3362291EQ30576758-67818A23-9A63-4B5C-8ED6-1300CE7C5D13Q30629677-B7722443-5392-492E-9F7B-888717679850Q30724476-C0DF1B81-F2EA-4A43-AA63-B063E8918993Q30791071-2B9E1215-4FDE-45AF-AC5F-A129FC3B0E1EQ30804806-60B533C0-C1A8-4223-8D1A-05E82018D259Q30844805-60A0DCE2-0D2E-462C-B88F-29778AEDF136Q30955512-EFDFAA1E-2939-4F77-9CCC-911171CF647DQ31142712-757FD658-B623-4A99-AE32-B1063240FC37Q33419082-3EBC8F3E-194C-4346-8914-7555E5F6CC9FQ33516504-1F86C127-BAEC-4415-8C60-8F2F1F9DEA39Q33516685-E693AB1F-C7F7-403A-B76E-31AC5242A66BQ33678007-589CC1C1-A775-428A-97ED-48C5CEC9182DQ33699097-9F1DE8BA-2689-4A5E-8ABA-28B4FF43FECBQ33906348-BFF897B8-F49F-43B7-9016-BFF3F868B580Q33915700-D07C2EAD-CA5E-445C-B550-2525EB604940Q33918377-BDDB9A1F-3D7B-4531-9904-321D768BE5F5Q33989306-CEF4F307-A739-4014-8A05-83FC2FB001A6Q34030400-0150C80C-1189-4921-98FF-A6DD3C317BB2Q34064751-ED6EB398-A098-4EA7-B7D8-38E59AF3A00D
P2860
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Use of nonsteroidal antiinflam ...... he American Heart Association.
@ast
Use of nonsteroidal antiinflam ...... he American Heart Association.
@en
Use of nonsteroidal antiinflam ...... he American Heart Association.
@nl
type
label
Use of nonsteroidal antiinflam ...... he American Heart Association.
@ast
Use of nonsteroidal antiinflam ...... he American Heart Association.
@en
Use of nonsteroidal antiinflam ...... he American Heart Association.
@nl
prefLabel
Use of nonsteroidal antiinflam ...... he American Heart Association.
@ast
Use of nonsteroidal antiinflam ...... he American Heart Association.
@en
Use of nonsteroidal antiinflam ...... he American Heart Association.
@nl
P2093
P1433
P1476
Use of nonsteroidal antiinflam ...... he American Heart Association.
@en
P2093
Alan Daugherty
Curt Furberg
Harold Roberts
Joel S Bennett
Kathryn A Taubert
P304
P356
10.1161/CIRCULATIONAHA.106.181424
P407
P577
2007-02-26T00:00:00Z